However, out of the 4 proteins that were significantly different between NMO/NMO-SD and MS, only 3 (cadherin–2, proactivator polypeptide and ICAM–2) turned out to be included in the 6-protein profile revealed by multivariate regression analysis. This evidence concerns the gene ICAM2 and myeloid sarcoma.